Guruduth Banavar

along with the molecular data.

So what we are able to do is now correlate what kinds of phenotypes are a result of what kind of molecular activity.

And we are starting to publish that data little by little.

Now you bring up microplastics, you bring up other kinds of toxins.

We're going to be publishing all that data from the phenotype and from the molecular activities that we already have in our data set.

So our data set is, you know, on the one hand, it's providing a service to individuals so people can take advantage of it and get the right nutritional habits in place.

But at the same time, it's also helping every person that comes after you because it goes back into an R&D sort of flywheel, if you will.

And we are able to turn that into new insights that we can tell the next person who comes by and ask for the same questions.

Nice.

You know, that's a very difficult question because there's no such thing as a single healthy microbiome.

There's many different ways of being healthy.

Yeah.

And I would say that, you know, people with very few pathways that are out of whack would be in the generally healthy category.

And that's definitely less than about 5% of the population.

Wow, 5%.

Yeah.

You know, that's where I would put it, just knowing the pathways that we measure and knowing the data of our individuals, right?

I'm talking about people who have very few pathways that are out of whack.

Yeah.

Now, there's a lot of different ways in which people's pathways can be out of whack, okay?